Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 53.9 | 200.6 | 0.9 | 0.8 | 1.0 | 27.5 | 1.1 | 1.6 |
| Revenue growth | -73.1% | 23414.3% | 4.8% | -14.8% | -96.5% | 2508.4% | -34.3% | -96.8% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | -86.6 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 53.9 | 200.6 | 0.9 | 87.4 | 1.0 | 27.5 | 1.1 | 1.6 |
| Gross margin | 100.0% | 100.0% | 100.0% | 10735.4% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 135.6 | 82.3 | 74.9 | 50.8 | 101.2 | 134.5 | 119.5 | 58.4 |
| General and administrative | 49.9 | 46.3 | 38.7 | 35.7 | 42.5 | 48.2 | 41.1 | 23.1 |
| EBIT | -131.6 | 72.0 | -112.7 | -85.7 | -158.9 | -155.3 | -159.5 | -79.9 |
| EBIT margin | -244.1% | 35.9% | -13216.2% | -10527.9% | -16634.0% | -564.2% | -15121.8% | -4974.3% |
| Pre-tax income | -125.6 | 71.9 | -111.4 | -77.3 | -156.1 | -157.6 | -159.0 | -79.9 |
| Income taxes | -8.7 | 4.9 | -0.3 | 0.4 | -0.5 | -4.4 | 1.1 | 0.7 |
| Tax rate | 6.9% | 6.9% | 0.3% | | 0.3% | 2.8% | | |
| Net income | -116.9 | 67.0 | -111.1 | -77.7 | -155.6 | -153.2 | -160.1 | -80.6 |
| Net margin | -217.0% | 33.4% | -13029.8% | -9542.6% | -16297.9% | -556.8% | -15176.1% | -5016.3% |
| |
| Diluted EPS | ($2.47) | $1.38 | ($2.78) | ($1.95) | ($3.93) | ($4.07) | ($4.66) | ($2.66) |
| Shares outstanding (diluted) | 47.4 | 48.5 | 39.9 | 39.9 | 39.6 | 37.7 | 34.4 | 30.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|